363
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients

, , , , , , , , , , & show all
Pages 115-121 | Received 19 Feb 2016, Accepted 04 Apr 2016, Published online: 10 May 2016

References

  • Fox RI. Sjögren's syndrome. Lancet. 2005;366:321–31.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:554–8.
  • Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.
  • Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American college of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken). 2012;64:475–87.
  • Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun. 2012;39:15–26.
  • Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol. 2001;28:2238–44.
  • Caramaschi P, Biasi D, Carletto A, Manzo T, Randon M, Zeminian S, et al. Sjögren's syndrome with anticentromere antibodies. Rev Rhum Engl Ed. 1997;64:785–8.
  • LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573–6.
  • Ramos-Casals M, Nardi N, Brito-Zerón P, Aguiló S, Gil V, Delgado G, et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006;35:312–21.
  • Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sjögren's syndrome: a retrospective descriptive analysis. Arthritis Res Ther. 2010;12:R47.
  • Earnshaw WC, Rothfield N. Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma. 1985;91:313–21.
  • Earnshaw W, Bordwell B, Marino C, Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies. J Clin Invest. 1986;77:426–30.
  • Muro Y, Sugimoto K, Okazaki T, Ohashi M. The heterogeneity of anticentromere antibodies in immunoblotting analysis. J Rheumatol. 1990;17:1042–7.
  • Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, et al. Distinct recognition of antibodies to centromere proteins in primary Sjögren's syndrome compared with limited scleroderma. Ann Rheum Dis. 2006;65:1028–32.
  • Saunders WS, Chue C, Goebl M, Craig C, Clark RF, Powers JA, et al. Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity. J Cell Sci. 1993;104:573–82.
  • Nicol L, Jeppesen P. Human autoimmune sera recognize a conserved 26 kD protein associated with mammalian heterochromatin that is homologous to heterochromatin protein 1 of Drosophila. Chromosome Res. 1994;2:245–53.
  • Iwai T, Muro Y, Sugimoto K, Matsumoto Y, Ohashi M. Clinical features of anti-chromo antibodies associated with anti-centromere antibodies. Clin Exp Immunol. 1996;105:285–90.
  • Muro Y, Yamada T, Iwai T, Sugimoto K. Epitope analysis of chromo antigen and clinical features in a subset of patients with anti-centromere antibodies. Mol Biol Rep. 1996;23:147–51.
  • Coppo P, Henry-Dessailly I, Rochette J, Lok C, Buendia B, Lassoued K. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein. Eur J Intern Med. 2013;24:868–71.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO3rd, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
  • Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344–7.
  • Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.
  • van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.
  • Himoto T, Tanaka N, Saito A, Muro Y, Sugiura K, Tani J, et al. Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients. Clin Res Hepatol Gastroenterol. 2015;39:222–9.
  • Muro Y, Sugimoto K, Himeno M, Ohashi M. The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen. J Dermatol. 1992;19:584–91.
  • Sugimoto K, Kuriyama K, Himeno M, Muro Y. Epitope mapping of human centromere autoantigen centromere protein C (CENP-C); heterogeneity of anti-CENP-C response in rheumatic diseases. J Rheumatol. 1998;25:74–81.
  • Muro Y, Azuma N, Onouchi H, Kunimatsu M, Tomita Y, Sasaki M, et al. Autoepitopes on autoantigen centromere protein-A (CENP-A) are restricted to the N-terminal region, which has no homology with histone H3. Clin Exp Immunol. 2000;120:218–23.
  • Hayashi Y, Muro Y, Kuriyama K, Tomita Y, Sugimoto K. Differences in specificities of anti-centromere sera for the monomeric and dimeric C-terminal peptides of human centoromere protein C. Int Immunol. 2000;12:1431–7.
  • Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol. 1968;21:656–60.
  • Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, et al. Validation of different sets of criteria for the diagnosis of Sjögren's syndrome in Japanese patients. Mod Rheumatol. 2013;23:219–25.
  • Tan EM, Muro Y, Pollard KM. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol. 1994;12 (Suppl 11):27–31.
  • Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun. 2010;35:256–64.
  • Mahler M, Mierau R, Genth E, Blüthner M. Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis. Arthritis Rheum. 2002;46:1866–72.
  • Baer AN, Medrano L, McAdams-Demarco M. Anti-centromere antibodies are associated with more severe exocrine glandular dysfunction in primary Sjögren's syndrome: an analysis of the Sjögren's international collaborative clinical alliance (SICCA) cohort. Scand J Immunol. 2015;81:397–8.
  • Szántó A, Nagy G, Zeher M. Characterization of anti-centromere antibody positive Sjögren's syndrome in a Hungarian center. Scand J Immunol. 2015;81:398.
  • Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatol Int. 2006;26:298–303.
  • Saito A, Muro Y, Sugiura K, Akiyama M. Low prevalence of autoantibodies to CENP-H, -I, -K, -L, -M, -N, -T and -U in a Japanese cohort of anti-centromere positive samples. Immunopharmacol Immunotoxicol. 2013;35:57–63.
  • Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Mod Rheumatol. 2013;23:841–5.
  • Robitaille G, Christin MS, Clément I, Senécal JL, Raymond Y. Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells. Arthritis Rheum. 2009;60:2805–16.
  • Pourmand N, Wahren-Herlenius M, Gunnarsson I, Svenungsson E, Löfström B, Ioannou Y, et al. Ro/SSA and La/SSB specific IgA antibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis. 1999;58:623–9.
  • Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X, et al. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome. J Rheumatol. 2007;34:2253–8.
  • Nakamura H, Kawakami A, Hayashi T, Iwamoto N, Okada A, Tamai M, et al. Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord. 2010;11:140.
  • Kitagawa T, Shibasaki K, Toya S. Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome. Clin Rheumatol. 2012;31:105–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.